U.S. flag An official website of the United States government
  1. Home
  2. For Federal, State, Local, Tribal, and Territorial Officials
  3. Funding Opportunities
  4. Grants and Cooperative Agreements
  5. Scientific Conference Grant Program
  1. Grants and Cooperative Agreements

Scientific Conference Grant Program

What is the Scientific Conference Grant Program?

FDA recognizes the value of supporting high quality, small conferences and scientific meetings relevant to its public health mission. This funding opportunity supports small conferences or scientific meetings. Examples include a symposium, seminar, workshop or any formal meeting, whether conducted face-to-face or virtually. The purpose is to exchange information and explore a defined subject, issue, or area of concern impacting public health within the scope of the FDA's mission.

“PAR-19-306: FDA Support for Conferences and Scientific Meetings” is a unique funding opportunity that combines the application and award process for all participating Centers within the FDA. This consolidated announcement streamlines the application process for applicants. Prospective applicants will need to request advanced permission to apply to the FDA Center that is aligned with the foci areas of their conference or scientific meeting.

What funding is available?

Information regarding funding can be found in the funding opportunity announcement.

Applications are accepted twice per year. Application due dates for the current FOA (due by 11:59 Eastern Time on the application due date) are:

  • October 13, 2020
  • April 12, 2021
  • October 12, 2021
  • April 12, 2022
  • October 11, 2022

A letter requesting advance permission to submit a conference application is required and must be received via e-mail no later than eight (8) weeks prior to the application due date. Applications without advanced permission to apply by the cognizant funding office will not be accepted or reviewed. The requirements for the Letters of Intent can be found in the funding opportunity announcement.

Who may I contact for more information?

Specific questions on this program can be directed to the appropriate Office of Partnerships' contact within the Division of Partnership Investments and Agreements. Please visit the Office of Partnerships Contacts webpage to obtain a downloaded version of the staffing roster. 

General questions may be directed to the Office of Partnerships' general mailbox: op.feedback@fda.hhs.gov.

Back to Top